INHIBITEC ANTICUERPOS SL
Company details
- Active NIF/CIF: B39875489
-
-
-
-
Address: Pl. Velarde, 5, 39003 Santander, Cantabria, España See in map
-
-
Featured products:
More information on INHIBITEC ANTICUERPOS SL
-
26/11/2020 | BORME act no.: 414287 | Register: CANTABRIAAmpliación de capital
-
26/11/2020 | BORME act no.: 414287 | Register: CANTABRIAAmpliación de capital
-
26/11/2020 | BORME act no.: 414288 | Register: CANTABRIAAmpliación de capital
-
26/11/2020 | BORME act no.: 414288 | Register: CANTABRIACambio de domicilio social
-
10/10/2019 | BORME act no.: 421004 | Register: CANTABRIAConstitución
-
10/10/2019 | BORME act no.: 421004 | Register: CANTABRIANombramientos
Other information
The CIF assigned to INHIBITEC ANTICUERPOS SL is B39875489, while its current business status is active. The company operates in the economic sector identified by the CNAE 7211 - Investigación y desarrollo experimental en biotecnología. In addition, its activity corresponds to the SIC classification -.
The template of INHIBITEC ANTICUERPOS SL includes Between 1 and 9 employees, and the company reports an annual turnover of less than 2 million euros. INHIBITEC ANTICUERPOS SL is registered in the Mercantile Registry of Cantabria and accumulates a total of 1 registration charges. The most recent announcement in Borme was published on 26/11/2020, while its last deposit of ordinary annual accounts is related to the 2023 exercise.
If you want to obtain contact information for INHIBITEC ANTICUERPOS SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about INHIBITEC ANTICUERPOS SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about INHIBITEC ANTICUERPOS SL comes from official data sources and is automatically updated every day.
Do you want to know more about INHIBITEC ANTICUERPOS SL??
Find out more about this company by consulting these reports: